On Apr. 15, 2020, NanoString Technologies announced the first publication utilizing the nCounter platform and its leading gene expression panels for measuring immune response in COVID-19 research.

Work published in the journal Cell Host & Microbe by a team of scientists from the Viral Research and Experimental Medicine Centre, a unit of the SingHealth Duke-NUS Academic Medical Centre, outlined the differences in host immune response to SARS-CoV-2 infections in their publication titled, ‘A Dynamic Immune Response Shapes COVID-19 Progression.’